Thomas Condamine

Thomas Condamine is an early development leader in immunotherapy, currently serving as the Chief Development Officer at SIGNADORI BIO. They hold a part-time position on the Scientific Advisory Board at NeoGenomics Laboratories. Thomas previously worked as the Sr Director of Discovery and Translational Sciences and later as Vice President in the same field at Carisma Therapeutics, where they guided strategic vision for clinical and pre-clinical studies. They earned a Master's degree and a PhD in Immunology from Université Paris Sud and the University of Nantes, respectively, and have held positions as a Staff Scientist at The Wistar Institute and a Postdoctoral Fellow at H. Lee Moffitt Cancer Center.